Quantitative analysis of double immunofluorescence staining of PIP3 and neuronal marker MAP2 in the midbrain sections of control and PD patients revealed a higher level of neuronal PIP3 immunoreactivity in PD samples compared to controls (Fig. 8c, d). Here, MAP2 is linked to Parkinson disease.